BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sophiris Bio Inc.  

1258 Prospect Street

La Jolla  California  92037  U.S.A.
Phone: 858-777-1760 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Sophiris Bio Inc. (SHS.TO) To Present At The 13th Annual Needham Healthcare Conference 3/26/2014 6:37:43 AM    More...
Sophiris Bio Inc. (SHS.TO) Adds Gerald T. Proehl To Its Board Of Directors 3/20/2014 6:41:38 AM    More...
Sophiris Bio Inc. (SHS.TO) Reports Fourth Quarter And Full Year 2013 Financial Results And Key Operational Highlights 3/14/2014 7:16:48 AM    More...
Sophiris Bio Inc. (SHS.TO) To Present At The Cowen and Company 34th Annual Health Care Conference 2/26/2014 7:31:45 AM    More...
Sophiris Bio Inc. (SHS.TO) To Present At The 2014 Leerink Swann and Company Global Healthcare Conference 2/4/2014 7:36:58 AM    More...
Sophiris Bio Inc. (SHS.TO) Reports Third Quarter Financial Results And Recent Key Operational Highlights 11/13/2013 7:51:41 AM    More...
Sophiris Bio Inc. (SHS.TO) Applies for Voluntary Delisting From TSX 11/6/2013 9:50:39 AM    More...
Sophiris Bio Inc. (SHS.TO) Announces First Patients Dosed in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia 10/29/2013 9:59:56 AM    More...
Sophiris Bio Inc. (SHS.TO) to Present at the Stifel Healthcare Conference 9/6/2013 6:21:21 AM    More...
Sophiris Bio Inc. (SHS.TO) Closes $65 Million Public Offering 8/23/2013 8:24:52 AM    More...
123

//-->